Tiquizium is a potent antimuscarinic agent that induces bronchodilation, making it a relevant tool for studying airway diseases like COPD. Its mechanism supports research into muscarinic receptor pharmacology in both in vitro binding assays and in vivo models of obstructive pulmonary conditions.
Molekulargewicht:
330.53
Reinheit:
99.82% (May vary between batches)
CAS Nummer:
[149755-23-7]
Formel:
C19H24NS2
Target-Kategorie:
AChR
Anwendungsbeschreibung:
Solubility: DMSO:50 mg/mL (151.27 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten